JAML and relapsing-remitting multiple sclerosis: During relapsing-remitting multiple sclerosis (RRMS), JAML is proposed to mediate CNS leukocyte migration through heterotypic interactions with CAR in the choroid epithelial cells of the blood-brain barrier.